Loading clinical trials...
Loading clinical trials...
Prospective Cohort Study on the Relationship Between Peroxiredoxin 1 (PRDX1) in Blood Exosomes From Colorectal Cancer Radical Resection Specimens and Postoperative Liver Metastasis
Conditions
Interventions
Observation
Locations
1
China
Shanghai Tongji Hospital, Hepatobilliary Surgery Center, Tongji University
Shanghai, Shanghai Municipality, China
Start Date
February 15, 2021
Primary Completion Date
November 30, 2026
Completion Date
November 30, 2026
Last Updated
February 6, 2026
NCT02600949
NCT07446322
NCT05919264
NCT07541924
NCT07537491
NCT07536113
Lead Sponsor
Mu-qing Yang
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions